B. Riley Issues Pessimistic Estimate for IperionX Earnings

Key Points

• B. Riley has revised its earnings estimate for IperionX, projecting a loss of ($0.12) per share for FY2025, down from a previous estimate of ($0.08).
• The consensus estimate for IperionX's full-year earnings currently stands at ($0.08) per share, indicating concerns about profitability.
• Despite the pessimistic forecast, the stock has received a "buy" rating from Roth Capital, with a target price of $64.00, and the average rating for the stock is currently "Buy" with a target of $46.00.

IperionX Limited Sponsored ADR (NASDAQ:IPX - Free Report) - Research analysts at B. Riley dropped their FY2025 EPS estimates for IperionX in a research note issued to investors on Thursday, September 11th. B. Riley analyst N. Giles now anticipates that the company will post earnings of ($0.12) per share for the year, down from their prior forecast of ($0.08). The consensus estimate for IperionX's current full-year earnings is ($0.08) per share. B. Riley also issued estimates for IperionX's FY2026 earnings at ($0.07) EPS, FY2027 earnings at $0.08 EPS and FY2028 earnings at $0.43 EPS.

A number of other research firms also recently commented on IPX. Wall Street Zen raised IperionX from a "sell" rating to a "hold" rating in a research note on Friday, June 6th. Roth Capital began coverage on IperionX in a report on Wednesday, August 20th. They set a "buy" rating and a $64.00 target price on the stock. Two analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock presently has an average rating of "Buy" and an average price target of $46.00.

IperionX Price Performance

Shares of NASDAQ:IPX opened at $44.58 on Monday. IperionX has a 12 month low of $12.27 and a 12 month high of $49.46. The stock's 50 day moving average price is $39.58 and its 200 day moving average price is $28.27.

Hedge Funds Weigh In On IperionX

Several institutional investors and hedge funds have recently bought and sold shares of the business. GAMMA Investing LLC boosted its holdings in shares of IperionX by 684.4% during the second quarter. GAMMA Investing LLC now owns 957 shares of the company's stock worth $30,000 after purchasing an additional 835 shares during the period. Cape Investment Advisory Inc. purchased a new position in shares of IperionX during the 2nd quarter valued at $34,000. JPMorgan Chase & Co. acquired a new position in shares of IperionX in the second quarter worth $66,000. Atlantic Union Bankshares Corp purchased a new stake in shares of IperionX during the second quarter worth $220,000. Finally, Citadel Advisors LLC acquired a new stake in IperionX during the fourth quarter valued at $283,000. Hedge funds and other institutional investors own 2.76% of the company's stock.

About IperionX

IperionX's mission is to be the leading developer of low carbon, sustainable, critical material supply chains focused on advanced industries including space, aerospace, electric vehicles and 3D printing. IperionX's breakthrough titanium technologies have demonstrated the potential to produce titanium products that are sustainable, 100% recyclable, have low carbon intensity and to do so at product qualities that meet or exceed current industry standards.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.